Home » Poolbeg Pharma (POLB) » A landmark year for Poolbeg Pharma #POLB – Alan Green talks to CEO Jeremy Skillington

A landmark year for Poolbeg Pharma #POLB – Alan Green talks to CEO Jeremy Skillington

A landmark year for Poolbeg Pharma #POLB – Alan Green talks to CEO Jeremy Skillington, who takes us through what has been a very eventful year since the IPO. At 01:58 we discuss the flagship asset POLB 001, which reached a major milestone last week as it commenced a human challenge trial. At 05:00 Jeremy provides an overview of two collaborations in Artificial Intelligence and how Poolbeg will use these pioneering approaches to identify new treatments for infectious diseases. At 08:57 Jeremy outlines what investors should expect for the remainder of 2022.


Leave a comment

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.